PDE4A and Alzheimer disease: CircAXL knockdown can inhibit PDE4A by releasing miR‐1306‐5p, reduce apoptosis, inflammation, oxidative stress, and endoplasmic reticulum stress in AD cells, and reduce Aβ1–42‐induced neurotoxicity in AD pathology.189